Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma

Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma

Bibliographic Details
Main Authors:	Yanbing Dong, Ying Huang, Zhe Zhang, Aoxing Chen, Lin Li, Manman Tian, Jie Shen, Jie Shao
Format:	Article
Language:	English
Published:	BMC 2023-05-01
Series:	Journal of Translational Medicine
Online Access:	https://doi.org/10.1186/s12967-023-04162-y

Similar Items

iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
by: Yanbing Dong, et al.
Published: (2023-03-01)

Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
by: Jie Shao, et al.
Published: (2024-12-01)

iRGD‐Targeted Physalis Mottle Virus Like Nanoparticles for Targeted Cancer Delivery
by: Krister J. Barkovich, et al.
Published: (2023-08-01)

Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
by: Anna Egorova, et al.
Published: (2021-02-01)

Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
by: Chen J, et al.
Published: (2019-10-01)

iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma
by: Liu T, et al.
Published: (2025-01-01)

The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
by: Yingzheng Wang, et al.
Published: (2023-09-01)

iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma
by: Li H, et al.
Published: (2021-09-01)

Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus
by: Ahmed Abdullah Al-Zaher, et al.
Published: (2018-03-01)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
by: Anna Egorova, et al.
Published: (2023-08-01)

Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
by: Gye Lim Kim, et al.
Published: (2023-02-01)

Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
by: Atieh Yaghoubi, et al.
Published: (2023-07-01)

sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
by: Ying Huang, et al.
Published: (2017-04-01)

Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles
by: Huang J, et al.
Published: (2021-11-01)

iRGD-guided Tumor-penetrating Nanocomplexes for Therapeutic siRNA Delivery to Pancreatic Cancer
by: Lo, Justin H., et al.
Published: (2020)

Molecular Imaging of Steroid-Induced Osteonecrosis of the Femoral Head through iRGD-Targeted Microbubbles
by: Ping Zhao, et al.
Published: (2022-09-01)

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
by: Naiqing Ding, et al.
Published: (2019-03-01)

Ultrasound Molecular Imaging of Neovascularization for Evaluation of Endometrial Receptivity Using Magnetic iRGD-Modified Lipid-Polymer Hybrid Microbubbles
by: He Y, et al.
Published: (2022-12-01)

iRGD-modified exosomes-delivered BCL6 siRNA inhibit the progression of diffuse large B-cell lymphoma
by: Qinhua Liu, et al.
Published: (2022-08-01)

Combined Self-Assembled iRGD Polymersomes for Effective Targeted siRNA Anti-Tumor Therapy
by: Li D, et al.
Published: (2022-11-01)

iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
by: Gao F, et al.
Published: (2017-06-01)

Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
by: Zhang D, et al.
Published: (2020-01-01)

1197 Site-specific anti-PD-1-iRGD peptide conjugate boosts antitumor efficacy via enhancement of T cell penetration and engagement
by: Jie Li, et al.
Published: (2023-11-01)

Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma
by: Du R, et al.
Published: (2014-06-01)

Homing peptides (rgd/irgd) functionalized zeolitic imidazolate framework-8 for targeted delivery of gemcitabine to lung cancer cell
by: Mohd Abdul Kamal, Nurul Akmarina
Published: (2022)

iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer
by: Hou X, et al.
Published: (2024-08-01)

GSH-responsive SN38 dimer-loaded shape-transformable nanoparticles with iRGD for enhancing chemo-photodynamic therapy
by: Congcong Lin, et al.
Published: (2020-12-01)

The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation
by: Yu KF, et al.
Published: (2013-07-01)

Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model
by: Zheng-Hong Peng, et al.
Published: (2022-08-01)

MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization
by: Jouri S. Alanazi, et al.
Published: (2022-01-01)

99mTc-labeled iRGD for single-positron emission computed tomography imaging of triple-negative breast cancer
by: Buhui Yu, et al.
Published: (2022-09-01)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
by: Dan Lin, et al.
Published: (2021-12-01)

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
by: Anna Egorova, et al.
Published: (2020-10-01)

Co-Entrapment of Sorafenib and Cisplatin Drugs and iRGD Tumour Homing Peptide by Poly[ε-caprolactone-co-(12-hydroxystearate)] Copolymer
by: Izolda Kántor, et al.
Published: (2021-12-01)

A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD.
by: Qing Zhang, et al.
Published: (2015-01-01)

iRGD-guided tamoxifen polymersomes inhibit estrogen receptor transcriptional activity and decrease the number of breast cancer cells with self-renewing capacity
by: María Inés Diaz Bessone, et al.
Published: (2019-12-01)

Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment
by: Zhong Y, et al.
Published: (2019-11-01)

Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy
by: Liu X, et al.
Published: (2021-02-01)

An iRGD‐conjugated photothermal therapy‐responsive gold nanoparticle system carrying siCDK7 induces necroptosis and immunotherapeutic responses in lung adenocarcinoma
by: Rui Cai, et al.
Published: (2023-07-01)

Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia
by: Dong, Han, et al.
Published: (2022)